Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antioxidant and Anti-inflammatory in DIEP Flap Ischemia-Reperfusion
NCT00821158Phase 3Unknown
- Sponsor
- Maastricht University Medical Center+
- Start
- Feb 2009
- Primary completion
- Feb 2011
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of antioxidant gel in ischemia-reperfusion injury (IRI) (3 arms), sponsored by Maastricht University Medical Center+. Primary endpoint: Antioxidant concentrations. Status: unknown.
02
Drugs
antioxidant gel
03
Conditions
ischemia-reperfusion injury (IRI)
Beyond the preview
Go deeper on NCT00821158.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00821158.